Insulet
PODD
#986
Rank
A$31.66 B
Marketcap
$451.40
Share price
1.63%
Change (1 day)
53.91%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.61

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.69. In 2022 the company made an earnings per share (EPS) of $0.11 a decrease over its 2021 EPS that were of $0.36.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.612284.88%
2022$0.11-69.57%
2021$0.36109.09%
2020$0.17-38.89%
2019$0.28200%
2018$0.09395-113.04%
2017-$0.72-9.8%
2016-$0.80-60.77%
2015-$2.0439.78%
2014-$1.4612.05%
2013-$1.30-23.15%
2012-$1.6910.2%
2011-$1.53-36.36%
2010-$2.41-36.63%
2009-$3.80-29.36%
2008-$5.39-86.74%
2007-$40.62-64.04%
2006-$112.97122.23%
2005-$50.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.16-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.06-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.53-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.05 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.65 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.26 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.50 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA